Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Economic issues in lung cancer.

L Bordeleau1, P J Goodwin

  • 1Department of Medicine, Toronto-Sunnybrook Regional Cancer Centre, Ontario, Canada.

Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
PubMed
Summary

Lung cancer management is moderately expensive, but current diagnostic and treatment approaches are largely cost-effective. Further exploration is needed into inconsistent medical practices for lung cancer care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetes, metformin and breast cancer: a tangled web.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer.

Breast cancer research and treatment·2012
Same author

Does family history predict the age at onset of new breast cancers in BRCA1 and BRCA2 mutation-positive families?

Clinical genetics·2009
Same author

Prognosis of BRCA-associated breast cancer: a summary of evidence.

Breast cancer research and treatment·2009
Same author

Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG).

Annals of oncology : official journal of the European Society for Medical Oncology·2006
Same author

The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.

Leukemia·2005

Area of Science:

  • Health Economics
  • Oncology
  • Public Health

Background:

  • Lung cancer presents a significant societal cost due to its high incidence.
  • Effective management strategies are crucial to mitigate economic burdens.
  • Variations in clinical practice necessitate an economic evaluation.

Purpose of the Study:

  • To review the economics of lung cancer management.
  • To analyze the costs associated with diagnosis, treatment, and palliation.
  • To assess the cost-effectiveness of current lung cancer interventions.

Main Methods:

  • A comprehensive review of economic and methodological literature.
  • Analysis of costs related to lung cancer diagnosis, staging, and treatment.
  • Evaluation of cost-effectiveness of combined modality therapy and palliative chemotherapy.

Main Results:

  • Lung cancer treatment is moderately expensive, contributing to significant overall societal costs.
  • Judicious use of diagnostic and staging procedures can minimize costs.
  • Combined modality therapy and palliative chemotherapy demonstrate reasonable cost-effectiveness.

Conclusions:

  • Current lung cancer diagnosis and treatment strategies are generally cost-effective.
  • Optimizing diagnostic procedures can reduce staging costs.
  • Investigating the reasons behind inconsistent clinical practice patterns in lung cancer management is recommended.

Related Experiment Videos